Unknown

Dataset Information

0

Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.

ABSTRACT: This study assessed the adherence profiles to inhaled therapies and the agreement between two patient self-report adherence methods in stable COPD lpatients from seven Latin American countries.This observational, cross-sectional, multinational, multicenter study involved 795 COPD patients (post-bronchodilator forced expiratory volume in 1 second/forced vital capacity [FEV1/FVC] <0.70). Adherence to inhaled therapy was assessed using the specific Test of Adherence to Inhalers (10-item TAI) and the generic 8-item Morisky Medication Adherence Scale (MMAS-8) questionnaires. The percentage agreement and the kappa index were used to compare findings.59.6% of patients were male (69.5±8.7 years); post-bronchodilator FEV1 percent predicted was 50.0±18.6%. Mean values for 10-item TAI and MMAS-8 questionnaires were 47.4±4.9 and 6.8±1.6, respectively. Based on the TAI questionnaire, 54.1% of patients had good, 26.5% intermediate, and 19.4% poor adherence. Using the MMAS-8 questionnaire, 51% had high, 29.1% medium, and 19.9% low adherence. According to both questionnaires, patients with poor adherence had lower smoking history, schooling but higher COPD Assessment Test score, exacerbations in the past-year and post-bronchodilator FEV1. The agreement between 10-item TAI and MMAS-8 questionnaires was moderate (Kappa index: 0.42; agreement: 64.7%).Suboptimal adherence to medication was frequent in COPD patients from Latin America. Low adherence was associated with worse health status impairment and more exacerbations. There was inadequate agreement between the two questionnaires. Greater effort should be made to improve COPD patients' adherence to treatment, and assessment of adherence with more specific instruments, such as the TAI questionnaire, would be more convenient in these patients.NCT02789540.

SUBMITTER: Montes de Oca M 

PROVIDER: S-EPMC5687703 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

<h4>Background</h4>This study assessed the adherence profiles to inhaled therapies and the agreement between two patient self-report adherence methods in stable COPD lpatients from seven Latin American countries.<h4>Methods</h4>This observational, cross-sectional, multinational, multicenter study involved 795 COPD patients (post-bronchodilator forced expiratory volume in 1 second/forced vital capacity [FEV1/FVC] <0.70). Adherence to inhaled therapy was assessed using the specific Test of Adheren  ...[more]

Similar Datasets

Unknown Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
| S-EPMC5955011 | biostudies-literature
Unknown Life expectancy with and without cognitive impairment in seven Latin American and Caribbean countries.
| S-EPMC4370415 | biostudies-literature
Unknown Cross-national measurement invariance of the Purpose in Life Test in seven Latin American countries.
| S-EPMC9524452 | biostudies-literature
Unknown Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.
| S-EPMC5743110 | biostudies-other
Unknown Energy intake and food sources of eight Latin American countries: results from the Latin American Study of Nutrition and Health (ELANS).
| S-EPMC10260935 | biostudies-literature
Unknown Diet Quality and Diet Diversity in Eight Latin American Countries: Results from the Latin American Study of Nutrition and Health (ELANS).
| S-EPMC6682987 | biostudies-literature
Unknown Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
| S-EPMC5401386 | biostudies-other
Unknown Responses to COVID-19 in five Latin American countries.
| S-EPMC7451099 | biostudies-literature
Unknown Optimizing Tobacco Advertising Bans in Seven Latin American Countries: Microsimulation Modeling of Health and Financial Impact to Inform Evidence-Based Policy.
| S-EPMC8151006 | biostudies-literature
Unknown COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study.
| S-EPMC4830516 | biostudies-literature